Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis

Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis

Abstract Background Early onset fetal growth restriction secondary to placental insufficiency can lead to severe maternal and neonatal morbidity and mortality. Pre-clinical studies and a few small randomised clinical trials have suggested that phosphodiesterase type 5 (PDE-5) inhibitors may have pro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jessica Liauw, Katie Groom, Wessel Ganzevoort, Christian Gluud, Christopher J. D. McKinlay, Andrew Sharp, Laura Mackay, Chirag Kariya, Ken Lim, Peter von Dadelszen, Jacqueline Limpens, Janus C. Jakobsen, the STRIDER Consortium
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Fetal growth restriction
Phosphodiesterase type 5 inhibitor
Randomised clinical trial
Trial sequential analysis
Aggregate meta-analysis
Individual patient data meta-analysis
Medicine
R
Acceso en línea:https://doaj.org/article/79c934a25fd948e0a218890e5020aafc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares